Literature DB >> 4610003

Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon").

I Valverde, M L Villanueva, I Lozano, J Marco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4610003     DOI： 10.1210/jcem-39-6-1090

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  33 in total

1.  Plasma glucagon immunoreactivity in a totally pancreatectomized patient.

Authors:  M L Villanueva; J A Hedo; J Marco
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

2.  Immunohistochemical demonstration of alpha-1-antitrypsin in the islet cells of human pancreas.

Authors:  M B Ray; V J Desmet
Journal:  Cell Tissue Res       Date:  1978-02-14       Impact factor: 5.249

3.  Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.

Authors:  S F Kuku; J B Jaspan; D S Emmanouel; A Zeidler; A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

Review 4.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

5.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

6.  The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.

Authors:  F Jockenhövel; S Lederbogen; T Olbricht; H Schmidt-Gayk; E P Krenning; S W Lamberts; D Reinwein
Journal:  Clin Investig       Date:  1994-01

7.  Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.

Authors:  T J Johnson; E M Quigley; T E Adrian; G Jin; L F Rikkers
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.

Authors:  S Del Prato; A Rovira; P Tessari; A Avogaro; R Nosadini; I Valverde; R Trevisan; A Tiengo
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

9.  Metabolic studies in total parenteral nutrition with lipid in man. Comparison with glucose.

Authors:  K N Jeejee hoy; G H Anderson; A F Nakhooda; G R Greenberg; I Sanderson; E B Marliss
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

10.  The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats.

Authors:  J C Dunbar; M F Walsh; P P Foà
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.